<DOC>
	<DOCNO>NCT00164801</DOCNO>
	<brief_summary>The effect baclofen ( GABAB agonist ) , diltiazem ( muscle relaxant ) placebo compare double-blinded randomize study treatment NCCP . Cerebral cortical , brainstem spinal evoked potential treatment evaluate . Results study shed light pathogenesis treatment NCCP Chinese.We hypothesize Baclofen alleviate visceral hyperalgesia NCCP patient suppress afferent sensory pathway .</brief_summary>
	<brief_title>Effect GABAB Agonist Visceral Hyperalgesia NCCP patientsChinese ?</brief_title>
	<detailed_description />
	<mesh_term>Chest Pain</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<mesh_term>GABA-B Receptor Agonists</mesh_term>
	<criteria>Consecutive patient monthly anginalike chest pain negative coronary angiogram scintigraphy Age 1870 Gastroesophageal reflux disease Psychiatric illness Cerebrovascular accident Active peptic ulceration Heart failure cardiac bradyarrhythmia Epilepsy Pregnancy lactate female Previous hypersensitivity muscle relaxant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>